Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Early Detection Of Alpha-Synuclein Disease

    The purpose of this study is to test an investigational laboratory test which may be able to detect asynuclein (a protein) from skin biopsies of ...

    View Details

  • The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD) A Double-Blinded Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib

    The purpose of the study is to determine if the invasive disease-free survival (iDFS) with T-DM1 and tucatinib is superior to the iDFS in the ...

    View Details

  • MomiVax Immune Response and Safety of COVID-19 Vaccines Administered to Pregnant and Postpartum People and Evaluation of Antibody Transfer to Infants (NIAID NIH)

    The NYU Langone Vaccine Center’s sites in Manhattan and Brooklyn are taking part in a NIAID funded, observational study for people who are pregnant ...

    View Details

  • The Stop Flu NYU cohort study

    This study is being conducted to study the body’s response to the seasonal influenza vaccination and to learn about the protection from infection with ...

    View Details


    The main reason this research study is being done is to see if an additional COVID-19 vaccine (a booster) will help people with autoimmune disease ...

    View Details

  • Performance Evaluation of 3D DIXON MRI of Joints

    The purpose of this study is to develop a method for faster MRI of joints. This study will test whether this new technique is reliable ...

    View Details

  • A Phase 1b/2 Randomized Study of AVB-S6-500 Plus Nab-paclitaxel and Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    The purpose of the study is to evaluate the safety and efficacy of AVB-S6-500 in combination with nab-paclitaxel and gemcitabine in subjects with locally advanced ...

    View Details

  • APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1 BRCA2 or PALB2 Mutation

    This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that ...

    View Details